AVEO Pharmaceuticals (NASDAQ:AVEO) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate of $(0.25) by 20 percent. This is a 62.96 percent increase over losses of $(0.81) per share from the same period last year. The company reported quarterly sales of $20.92 million which beat the analyst consensus estimate of $20.65 million by 1.31 percent. This is a 989.58 percent increase over sales of $1.92 million the same period last year.
AVEO Pharmaceuticals Q1 EPS $(0.30) Misses $(0.25) Estimate, Sales $20.92M Beat $20.65M Estimate
AVEO Pharmaceuticals (NASDAQ:AVEO) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate of $(0.25) by 20 percent. This is a 62.96 percent increase over losses of $(0.81) per share
